CM
SGMO

Caption Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Caption Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-55,700
Closed -$36.5K – 1840
2025
Q1 		$36.5K Buy
+55,700
New +$59K ﹤0.01% 1400
2023
Q1 		– Sell
-28,100
Closed -$88.2K – 1490
2022
Q4 		$88.2K Buy
+28,100
New +$109K ﹤0.01% 1141
2022
Q3 		– Sell
-44,100
Closed -$183K – 1810
2022
Q2 		$183K Hold
44,100
– – ﹤0.01% 1247
2022
Q1 		$257K Sell
44,100
-2,376
-5% -$14.1K ﹤0.01% 1241
2021
Q4 		$349K Buy
46,476
+21,376
+85% +$186K ﹤0.01% 1335
2021
Q3 		$226K Buy
25,100
+2,335
+10% +$23.1K ﹤0.01% 1329
2021
Q2 		$273K Sell
22,765
-46,441
-67% -$526K ﹤0.01% 1143
2021
Q1 		$867K Buy
69,206
+62,206
+889% +$838K 0.02% 709
2020
Q4 		$109K Buy
+7,000
New +$82K ﹤0.01% 877
2020
Q2 		– Sell
-25,000
Closed -$232K – 1161
2020
Q1 		$160K Buy
+25,000
New +$186K 0.01% 727
2018
Q3 		– Sell
-61,667
Closed -$876K – 632
2018
Q2 		$876K Buy
+61,667
New +$1.02M 0.07% 263

Other funds holding SGMO

YAG
Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Caption Management's SGMO Position: Q2 2025 in Review

Caption Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2025, closing a stake of 55,700 shares — an estimated $36.5K sold.

Caption Management first reported a position in SGMO in Q2 2018 and held it in 11 quarters. The position peaked at $876K in Q2 2018. 114 funds tracked by Wall St. Rank hold SGMO as of Q2 2025.

  • Caption Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2025 after selling out during the quarter.
  • Caption Management sold 55,700 SANGAMO THERAPEUTICS INC shares in Q2 2025, an estimated $36.5K.
  • Caption Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2018 and held it in 11 quarters.
  • Caption Management's SANGAMO THERAPEUTICS INC position peaked at $876K in Q2 2018.
  • 114 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2025.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.